Cargando…
Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis
OBJECTIVE: Current evidence on the effectiveness of SARS-CoV-2 prophylaxis is inconclusive. We aimed to systematically evaluate published studies on repurposed drugs for the prevention of laboratory-confirmed SARS-CoV-2 infection and/or COVID-19 among healthy adults. DESIGN: Systematic review. ELIGI...
Autores principales: | Zhou, Guiling, Verweij, Stefan, Bijlsma, Maarten J, de Vos, Stijn, Oude Rengerink, Katrien, Pasmooij, Anna Maria Gerdina, van Baarle, Debbie, Niesters, Hubert G M, Mol, Peter, Vonk, Judith M, Hak, Eelko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462970/ https://www.ncbi.nlm.nih.gov/pubmed/37640510 http://dx.doi.org/10.1136/bmjresp-2023-001674 |
Ejemplares similares
-
Community Use of Repurposed Drugs Before and During COVID-19 Pandemic in the Netherlands: An Interrupted Time-Series Analysis
por: Zhou, Guiling, et al.
Publicado: (2023) -
Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients
por: Hérivaux, Anaïs, et al.
Publicado: (2022) -
Rationale for azithromycin in COVID-19: an overview of existing evidence
por: Gyselinck, Iwein, et al.
Publicado: (2021) -
Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trial
por: van den Berk, Inge A H, et al.
Publicado: (2023) -
A novel immunomodulatory function of neutrophils on rhinovirus-activated monocytes in vitro
por: Tang, Francesca S M, et al.
Publicado: (2016)